It may seem counter-intuitive or even wasteful to further outsource an already outsourced activity. After all isn’t outsourcing the way to completely remove your resource and expertise problem by engaging and pay for an end to end service. So why indeed appear to pay twice for what looks like the same thing?
Sponsors outsourcing drug development actvities are obliged by regulatory authorites to demonstrate overight of those activities. The sponsor is judged to be solely responsible for the work and whilst outsourced providers have accountability to the sponsor, this has to be demonstrated. most often by documents and records.
Often, it takes a lot more resource than sponsors first or subsequently realise to actually manage and delievr this oversight. Recent analysis off this area suggests only 1 in 5 sponsers believe they actually completely fund and resources their needs. In our experience, gathered over many years and numerous programs that failing will often lead to issues that are, at best costly to fix at a later date or simply just not possible. This can be especially true in those first critical steps in a regulatory development programme. So, avoiding that consequence can and does protect investments
Equally, importantly if you are outsourcing bioanalysis, it is critical to ensure that the oversight is performed by people that have expertise and experience in this area
Using our extensive experience A4P provide the resource, processes and expertise to deliver demonstrable oversight and effective managemant of outsourced bioanalysis.